ReviewTherapeutic advances in hematology2023

Therapy for patients with chronic phase-chronic myeloid leukemia previously treated with ⩾2 tyrosine kinase inhibitors: a systematic literature review.

Ehab Atallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.